Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if HIND is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 4
12 filers reported a long position in HIND for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| CITADEL ADVISORS LLC | $55.8K | 26K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $55.5K | 25.8K | Unchanged |
| HRT FINANCIAL LP | $43K | 20.3K | New |
| Focus Partners Wealth | $31.5K | 14.6K | Unchanged |
| VANGUARD FIDUCIARY TRUST CO | $26.2K | 12.2K | Unchanged |
| UBS Group AG | $25.6K | 11.9K | -47.5% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21.6K | 10.1K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $20.3K | 9.5K | Unchanged |
| ROYAL BANK OF CANADA | $13K | 5.9K | Unchanged |
| Tower Research Capital LLC (TRC) | $3.9K | 1.8K | +30% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.